Strategies for identifying the genetic basis of dyslipidemia: Genome-wide association studies vs. the resequencing of extremes

Current Opinion in Lipidology

Volumn 21, Issue 2, 2010, Pages 123-127

  Khor, Chiea Chuen ^a   Goh, Denise Li Meng ^b,c  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Dyslipidemia; Genome wide association study; Resequencing of extremes

Indexed keywords

ABC TRANSPORTER A1; GLYCOSYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; PROTEIN CELSR2; PROTEIN PSRC1; PROTEIN TRIB1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; COPY NUMBER VARIATION; DISEASE MARKER; DNA SEQUENCE; DYSLIPIDEMIA; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; COMPARATIVE STUDY; GENETICS; METHODOLOGY; REVIEW;

ANIMALS; DYSLIPIDEMIAS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 77957342967     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328336eae9     Document Type: Article

References (24)

1. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355:675-687. (Pubitemid 30107623)
2. Namboodiri KK, Kaplan EB, Heuch I, et al. The Collaborative Lipid Research Clinics Family study: biological and cultural determinantsoffamilial resemblance for plasma lipids and lipoproteins. Genet Epidemiol 1985; 2:227-254. (Pubitemid 15023349)
3. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921. (Pubitemid 32165345)
4. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17:502-510. (Pubitemid 32763048)
5. Kathiresan S, Manning AK, Demissie S, et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart study. BMC Med Genet 2007; 8 (Suppl 1):S17.
6. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008; 40: 161-169. (Pubitemid 351171403)
7. Sandhu MS, Waterworth DM, Debenham SL, et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008; 371:483-491. (Pubitemid 351199866)
8. Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009; 41:35-46.
9. Pollin TI, Damcott CM, Shen H, et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008; 322:1702-1705.
10. Kooner JS, Chambers JC, Aguilar-Salinas CA, et al. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet 2008; 40:149-151. (Pubitemid 351171393)
11. Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008; 40:189-197. (Pubitemid 351171402)
12. Aulchenko YS, Ripatti S, Lindqvist I, et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41:47-55.
13. Chasman DI, Pare G, Zee RY, et al. Genetic loci associated with plasma concentration of LDL-C, HDL-C, triglycerides, ApoA1, and ApoB among 6382 Caucasian women in genome-wide analysis with replication. Circ Cardiovasc Genet 2008; 1:21-30.
14. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009; 41:56-65.
15. Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009; 41:882-884.
16. Tai ES, Sim XL, Ong TH, et al. Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population. J Lipid Res 2009; 50:514-520.
17. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69:124-137. (Pubitemid 32614025)
18. Edmondson AC, Brown RJ, Kathiresan S, et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 2009; 119:1042-1050.
19. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 2004; 114:1343-1353. (Pubitemid 40385306)
20. Hu Y, Liu W, Huang R, Zhang X. A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 2006; 47:1908-1914. (Pubitemid 44401978)
21. Slatter TL, Jones GT, Williams MJ, et al. Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. Clin Genet 2008; 73:179-184.
22. Cohen JC, Kiss RS, Pertsemlidis A, et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305:869-872. (Pubitemid 39038422)
23. Fahmi S, Yang C, Esmail S, et al. Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes. Hum Mol Genet 2008; 17:2101-2107. (Pubitemid 351911979)
24. Maher B. Personal genomes: the case of the missing heritability. Nature 2008; 456:18-21.